Discordance of COVID‐19 guidelines for patients with cancer: A systematic review
Pankaj Kumar Garg, Pallvi Kaul, Deepti Choudhary, Kiran K. Turaga, Mahendra Pal Singh, Ajeet Ramamani Tiwari, Vipin Arora, Nishant Agrawal, Beat Rau, Sai Yendamuri
Abstract
This review was aimed to systematically evaluate the available literature on the impact of COVID-19 on cancer care and to critically analyze the diagnostic and therapeutic strategies suggested by various healthcare providers, societies, and institutions. Majority guidelines for various types of cancers favored a delay in treatment or a nonsurgical approach wherever feasible. These guidelines are based on a low level of evidence and have significant discordance for the role and timing of surgery, especially in early tumors.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BetacoronavirusCoronavirus InfectionsMEDLINEIntensive care medicineVirologyInternal medicineDiseaseOutbreakPolitical scienceInfectious disease (medical specialty)LawCOVID-19 and healthcare impactsEconomic and Financial Impacts of CancerAdvances in Oncology and Radiotherapy